Clinical Trial Update: Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma [Phase 2]

View source ↗

Summary

A Phase 2 trial of solriamfetol for sleep improvement in patients with glioma (grade II–IV) including glioblastoma was terminated, with results posted on 2025-1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Sunosi (solriamfetol)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Glioma, Glioblastoma | Phase 2 | Status: TERMINATED | Results posted: 2025-10-21